Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash Flows from Operating Activities:    
Net Loss $ (3,732,183) $ (4,363,567)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of Film and Television Costs 37,935 158,168
Depreciation Expense 51,527 49,637
Amortization Expense 43,771 57,763
Imputed Interest Expense 0 6,141
Stock Issued for Services 130,000 39,000
Stock Compensation Expense 514,108 1,236,880
Gain on Distribution Contracts 0 (258,103)
Loss on Impairment of Assets 0 1,850
Decrease (Increase) in Operating Assets    
Accounts Receivable (9,626) 220,285
Other Receivables (256,872) 0
Inventory (11,940) 518
Prepaid Expenses & Other Assets (73,877) (253,678)
Film and Television Costs, net (1,880,811) (754,770)
Increase (Decrease) in Operating Liabilities    
Accounts Payable (312,516) 66,247
Accrued Expenses (24,304) (274,042)
Deferred Revenue 476,655 2,159,120
Accrued Salaries and Wages 18,323 23,223
Net Cash Used in Operating Activities (5,029,810) (1,885,328)
Cash Flows from Investing Activities:    
Investment in Intangible Assets 0 (5,650)
Investment in Fixed Assets (47,361) (1,542)
Net Cash Used in Investing Activities (47,361) (7,192)
Cash Flows from Financing Activities:    
Proceeds from Warrant Exchange, Net 3,401,924 0
Proceeds from Exercise of Warrants 0 110,000
Proceeds from Production Facility, Net 2,034,728 237,567
Net cash provided by financing activities 5,436,652 347,567
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash 359,481 (1,544,953)
Beginning Cash, Cash Equivalents, and Restricted Cash 2,887,921 5,187,620
Ending Cash, Cash Equivalents, and Restricted Cash 3,247,402 3,642,667
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 2,827 1,450
Schedule of non-cash financing and investing activites:    
Issuance of Common Stock in Relation to Sony Transaction 1,489,583 0
Issuance of Common Stock in Satisfaction of Short Term Advances $ 0 $ 410,535